Cabot (NYSE:CBT) Cut to Hold at Wall Street Zen

Wall Street Zen downgraded shares of Cabot (NYSE:CBT) from a buy rating to a hold rating in a research report sent to investors on Saturday.

CBT has been the topic of several other research reports. Weiss Ratings reiterated a “hold (c)” rating on shares of Cabot in a research note on Tuesday, May 26th. Mizuho raised their price target on shares of Cabot from $80.00 to $90.00 and gave the company a “neutral” rating in a report on Thursday, June 25th. UBS Group raised their price target on shares of Cabot from $81.00 to $86.00 and gave the company a “neutral” rating in a report on Friday, May 8th. Truist Financial initiated coverage on shares of Cabot in a research report on Monday, June 8th. They issued a “buy” rating and a $98.00 price objective on the stock. Finally, JPMorgan Chase & Co. boosted their price objective on shares of Cabot from $68.00 to $70.00 and gave the stock an “underweight” rating in a research note on Wednesday, May 13th. Two investment analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $85.80.

Cabot Trading Up 2.2%

Shares of NYSE:CBT opened at $90.00 on Friday. Cabot has a 12-month low of $58.33 and a 12-month high of $94.53. The business’s fifty day simple moving average is $88.03 and its 200-day simple moving average is $79.56. The company has a market capitalization of $4.65 billion, a PE ratio of 17.01, a P/E/G ratio of 11.46 and a beta of 0.84. The company has a current ratio of 1.45, a quick ratio of 0.96 and a debt-to-equity ratio of 0.51.

Cabot (NYSE:CBT) last released its quarterly earnings results on Monday, August 3rd. The specialty chemicals company reported $1.67 EPS for the quarter, topping the consensus estimate of $1.66 by $0.01. The firm had revenue of $982.00 million during the quarter, compared to analyst estimates of $943.16 million. Cabot had a return on equity of 21.33% and a net margin of 7.97%.The business’s revenue for the quarter was up 6.4% compared to the same quarter last year. During the same period in the previous year, the company posted $1.90 EPS. Cabot has set its FY 2026 guidance at 6.150-6.450 EPS. As a group, equities research analysts predict that Cabot will post 6.35 earnings per share for the current fiscal year.

Cabot Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, September 11th. Investors of record on Friday, August 28th will be given a dividend of $0.4725 per share. This represents a $1.89 annualized dividend and a yield of 2.1%. The ex-dividend date of this dividend is Friday, August 28th. Cabot’s dividend payout ratio is currently 35.73%.

Institutional Investors Weigh In On Cabot

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in CBT. Public Employees Retirement System of Ohio increased its position in Cabot by 15.4% during the fourth quarter. Public Employees Retirement System of Ohio now owns 1,202 shares of the specialty chemicals company’s stock worth $80,000 after purchasing an additional 160 shares during the last quarter. Janney Montgomery Scott LLC boosted its holdings in shares of Cabot by 2.6% in the 4th quarter. Janney Montgomery Scott LLC now owns 6,298 shares of the specialty chemicals company’s stock valued at $417,000 after purchasing an additional 161 shares during the last quarter. Farther Finance Advisors LLC grew its stake in shares of Cabot by 9.6% during the 4th quarter. Farther Finance Advisors LLC now owns 1,873 shares of the specialty chemicals company’s stock valued at $124,000 after buying an additional 164 shares during the period. Parallel Advisors LLC grew its stake in shares of Cabot by 10.5% during the 1st quarter. Parallel Advisors LLC now owns 1,843 shares of the specialty chemicals company’s stock valued at $139,000 after buying an additional 175 shares during the period. Finally, Swiss Life Asset Management Ltd increased its holdings in shares of Cabot by 3.6% during the 2nd quarter. Swiss Life Asset Management Ltd now owns 6,147 shares of the specialty chemicals company’s stock worth $558,000 after buying an additional 212 shares during the last quarter. 93.18% of the stock is currently owned by hedge funds and other institutional investors.

Cabot Company Profile

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.